GORD and Dysphagia: Overlap Syndromes and Combined Management

Gastro-oesophageal reflux disease (GORD) and dysphagia are the two most common upper gastrointestinal symptoms in adults, and they frequently coexist. Their relationship is bidirectional: GORD can cause or worsen dysphagia through multiple mechanisms, and the presence of dysphagia can complicate GORD management. Understanding the overlap is essential for clinicians managing either condition.

In the United Kingdom and Hong Kong, GORD is the preferred term; the American abbreviation GERD is used in US literature. This article uses British spelling throughout.

This article follows ASHA Practice Portal guidance on adult dysphagia and NICE CG162.

How GORD Causes Dysphagia

Oesophageal Peptic Stricture

Chronic acid exposure to the lower oesophageal mucosa — particularly in patients with high-grade reflux and incomplete acid suppression — produces progressive fibrous scarring and luminal narrowing. This peptic stricture manifests as progressive solid food dysphagia, typically over years. It is the most common GORD-related cause of oesophageal dysphagia.

Risk is significantly increased if the patient has Barrett’s oesophagus (metaplastic change of the lower oesophageal epithelium), which itself is a pre-malignant condition requiring endoscopic surveillance.

Management: endoscopic dilatation plus high-dose PPI therapy. Recurrence is common without aggressive acid suppression.

Oesophageal Dysmotility

GORD causes oesophageal dysmotility through inflammatory injury to the smooth muscle of the oesophageal body. Acid exposure reduces peristaltic amplitude and propagation velocity, creating a hypomotile oesophagus that clears refluxate and food boluses slowly. This manifests as solid food dysphagia with sensation of food sticking in the chest, and prolonged oesophageal transit time.

Paradoxically, the dysmotility worsens GORD by reducing oesophageal acid clearance — a vicious cycle. High-resolution oesophageal manometry quantifies this dysmotility; it does not typically reach the severity of true achalasia but impairs quality of life.

Eosinophilic Oesophagitis (EoE)

An immune-mediated condition characterised by eosinophilic infiltration of the oesophageal epithelium. Presents with intermittent solid food dysphagia and food impaction, often in young to middle-aged adults with atopic disease. Historically conflated with refractory GORD (both improve with PPI in some patients), but now recognised as a distinct entity requiring dietary modification and/or topical steroids.

Diagnosis: endoscopy with biopsies showing >15 eosinophils per high-power field. Management: empirical food elimination diet (six-food elimination followed by reintroduction), topical oesophageal corticosteroids, endoscopic dilatation for strictures.

Laryngopharyngeal Reflux (LPR)

Laryngopharyngeal reflux — the upward migration of gastric contents to the larynx and pharynx — produces a distinct clinical syndrome that includes dysphagia, globus pharyngeus, chronic throat-clearing, dysphonia, and cough without the classic heartburn of GORD.

LPR damages the laryngeal and pharyngeal mucosa, impairing the sensory receptors that trigger the swallow reflex and the protective cough reflex. The consequences for dysphagia management are:

• Delayed swallow trigger (sensory receptor damage)
• Increased aspiration risk
• Chronic laryngeal mucosal oedema visible on FEES
• Increased pharyngeal secretion viscosity

Diagnosis is clinical and difficult to confirm objectively; pharyngeal pH-impedance monitoring can document reflux events at the laryngeal level. Most patients are treated empirically with twice-daily PPI and lifestyle modifications.

How Dysphagia Complicates GORD Management

Swallowing Medications

Patients prescribed PPI tablets, H2-antagonists, antacid liquids, and alginates for GORD may have difficulty swallowing their medication if they also have dysphagia. This leads to subtherapeutic acid suppression and ongoing GORD-driven oesophageal damage.

Solutions:

• Dispersible or soluble formulations — many PPIs are available as dispersible granules or oral suspensions
• Liquid antacids — generally well tolerated on IDDSI Level 3 or above; check viscosity
• Alginate rafts — available as liquids; typically IDDSI Level 3 thickness; effective for reducing laryngeal exposure to refluxate

Aspiration of Refluxate

In patients with both GORD and oropharyngeal dysphagia — a common combination in older adults and those with neurological conditions — gastric acid refluxing into the oropharynx can be aspirated during sleep or during periods of reduced consciousness. This aspiration of acidic gastric contents (aspiration pneumonitis/chemical injury) is distinct from bacterial aspiration pneumonia and requires different management (acid suppression, positional strategies, head-of-bed elevation rather than simply dietary texture modification).

Assessment

History

Key questions:

• Duration and severity of heartburn, regurgitation, acid taste
• Prior endoscopy and Barrett’s surveillance status
• Current acid suppression therapy and medication compliance
• Concurrent oropharyngeal dysphagia symptoms (timing of difficulty, coughing)
• Weight history

Investigation

• Upper GI endoscopy (OGD): assess for peptic stricture, Barrett’s oesophagus, oesophagitis grade (Los Angeles classification), EoE
• High-resolution oesophageal manometry: characterise oesophageal motility in patients with dysphagia plus GORD
• Ambulatory pH-impedance monitoring: quantify acid and non-acid reflux events; determine if reflux reaches the proximal oesophagus or hypopharynx (LPR)
• FEES: assess laryngeal mucosal condition in suspected LPR; identify secretion pooling and posterior laryngeal oedema

Management: Combined GORD and Dysphagia

Acid Suppression

High-dose PPI (twice daily before meals) is the cornerstone of GORD treatment. In patients with concomitant oropharyngeal dysphagia, compliance with oral medications must be actively addressed — dispersible formulations and liquid preparations should be prescribed.

Dietary Modifications

GORD dietary advice sometimes conflicts with dysphagia dietary advice. For example:

• GORD guidelines typically advise avoiding fatty foods, acidic foods, and large meals — but IDDSI puréed and mashed diets are often high in fat and dairy (to maintain caloric density)
• GORD advice often includes small, frequent meals — compatible with dysphagia management

A dietitian experienced in both conditions should be involved where both GORD and significant dysphagia coexist. In Hong Kong residential care settings, the HKCSS care food standards include guidance on meal timing and portion size relevant to both conditions.

Positional Strategies

• Head-of-bed elevation (20–30 cm head elevation) reduces nocturnal acid exposure
• Remaining upright for at least 30 minutes after eating — benefits both GORD and oropharyngeal dysphagia
• Lateral decubitus (left-side lying) reduces gastro-oesophageal junction exposure to acid

IDDSI Consideration

The IDDSI framework is applied for the oropharyngeal dysphagia component. There is no specific IDDSI modification for GORD alone. However, meal consistency choices should avoid unnecessarily acidic or gas-producing components that exacerbate reflux.

When to Refer

Patients with dysphagia and a history of long-standing GORD, Barrett’s oesophagus, or oesophagitis should be referred for OGD, gastroenterology review, and SLT assessment if oropharyngeal dysphagia is also present. See When to Refer to a Speech and Language Therapist.

References

1. American Speech-Language-Hearing Association. Adult Dysphagia Practice Portal. https://www.asha.org/practice-portal/clinical-topics/adult-dysphagia/
2. National Institute for Health and Care Excellence. Stroke Rehabilitation in Adults (CG162). https://www.nice.org.uk/guidance/cg162
3. IDDSI. The IDDSI Framework. https://www.iddsi.org/framework
4. Logemann JA, et al. (2015). Disorders of deglutition. Handbook of Clinical Neurology, 129, 465–487. PMID: 26315994